InnovAge (INNV) Competitors $2.98 -0.15 (-4.79%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$2.96 -0.02 (-0.67%) As of 04:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INNV vs. NHC, PACS, TDOC, VRDN, AHCO, CDNA, GRAL, PNTG, AVAH, and CSTLShould you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Grail (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry. InnovAge vs. National HealthCare PACS Group Teladoc Health Viridian Therapeutics AdaptHealth CareDx Grail The Pennant Group Aveanna Healthcare Castle Biosciences InnovAge (NASDAQ:INNV) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Do institutionals and insiders hold more shares of INNV or NHC? 12.3% of InnovAge shares are owned by institutional investors. Comparatively, 56.4% of National HealthCare shares are owned by institutional investors. 1.4% of InnovAge shares are owned by company insiders. Comparatively, 15.0% of National HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has higher valuation and earnings, INNV or NHC? National HealthCare has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovAge$806.61M0.50-$21.34M-$0.19-15.68National HealthCare$1.30B1.12$66.80M$6.5414.43 Is INNV or NHC more profitable? National HealthCare has a net margin of 10.03% compared to InnovAge's net margin of -3.19%. National HealthCare's return on equity of 6.87% beat InnovAge's return on equity.Company Net Margins Return on Equity Return on Assets InnovAge-3.19% -9.45% -4.84% National HealthCare 10.03%6.87%4.68% Which has more volatility and risk, INNV or NHC? InnovAge has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Does the MarketBeat Community favor INNV or NHC? National HealthCare received 3 more outperform votes than InnovAge when rated by MarketBeat users. Likewise, 100.00% of users gave National HealthCare an outperform vote while only 0.00% of users gave InnovAge an outperform vote. CompanyUnderperformOutperformInnovAgeOutperform VotesNo VotesUnderperform Votes5100.00% National HealthCareOutperform Votes3100.00% Underperform VotesNo Votes Does the media refer more to INNV or NHC? In the previous week, InnovAge had 1 more articles in the media than National HealthCare. MarketBeat recorded 3 mentions for InnovAge and 2 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.62 beat InnovAge's score of 1.18 indicating that National HealthCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive National HealthCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer INNV or NHC? InnovAge currently has a consensus target price of $5.00, indicating a potential upside of 67.79%. Given InnovAge's stronger consensus rating and higher possible upside, equities analysts clearly believe InnovAge is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNational HealthCare beats InnovAge on 14 of the 17 factors compared between the two stocks. Get InnovAge News Delivered to You Automatically Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INNV vs. The Competition Export to ExcelMetricInnovAgeHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$403.03M$832.17M$5.53B$7.93BDividend YieldN/A2.55%5.11%4.22%P/E Ratio-15.6852.8822.5118.54Price / Sales0.507.99397.62103.30Price / CashN/A26.1438.1834.62Price / Book1.573.966.734.25Net Income-$21.34M-$5.50M$3.22B$248.18M7 Day Performance-2.93%-3.17%1.38%1.03%1 Month Performance0.68%2.05%2.79%2.70%1 Year Performance-26.96%17.66%15.41%4.05% InnovAge Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INNVInnovAge1.3803 of 5 stars$2.98-4.8%$5.00+67.8%-23.2%$403.03M$806.61M-15.682,000Upcoming EarningsNews CoveragePositive NewsNHCNational HealthCareN/A$90.31-2.0%N/AN/A$1.40B$1.30B11.3212,400Positive NewsPACSPACS Group3.3662 of 5 stars$8.58-7.3%$34.00+296.3%-60.9%$1.31B$3.56B0.0032,433Positive NewsTDOCTeladoc Health3.8022 of 5 stars$6.52-4.5%$10.82+66.0%-45.5%$1.14B$2.57B-1.135,100Analyst ForecastVRDNViridian Therapeutics1.2429 of 5 stars$13.13flat$35.70+171.9%-0.5%$1.07B$302,000.00-3.0550Upcoming EarningsPositive NewsAHCOAdaptHealth3.4511 of 5 stars$7.33-5.9%$13.80+88.3%-15.5%$988.58M$3.26B-4.4410,900Upcoming EarningsCDNACareDx3.652 of 5 stars$16.94-3.9%$30.33+79.1%+64.2%$938.92M$333.79M-6.27740Earnings ReportPositive NewsGap DownGRALGrail0.7955 of 5 stars$26.42-2.1%$26.00-1.6%N/A$932.55M$125.60M0.001,360Positive NewsPNTGThe Pennant Group3.1686 of 5 stars$24.50-6.2%$34.80+42.0%+19.6%$850.69M$695.24M36.035,340Upcoming EarningsNews CoveragePositive NewsAVAHAveanna Healthcare1.0034 of 5 stars$4.22-7.0%$5.00+18.5%+101.8%$823.30M$2.02B-12.4133,000Upcoming EarningsNews CoverageCSTLCastle Biosciences3.0757 of 5 stars$21.14-1.7%$38.75+83.3%-12.3%$609.78M$332.07M105.71540Upcoming EarningsPositive News Related Companies and Tools Related Companies NHC Competitors PACS Competitors TDOC Competitors VRDN Competitors AHCO Competitors CDNA Competitors GRAL Competitors PNTG Competitors AVAH Competitors CSTL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INNV) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INNV Stock Free INNV Stock Alerts